Megna Michael R Insider Trading Activity
Corporate InsiderCHIEF ACCOUNTING OFFICER · CIK 1464583
6
Total trades
$3.6M
Total volume
Apr 9, 2026
Last activity
KNSA
Kiniksa Pharmaceuticals International, plc
Performance Scorecard
Forward stock performance after each transaction by Megna Michael R. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -9.7% | 17% | 6 |
| 90 days | — | -16.5% | 0% | 6 |
| 120 days | — | -29.1% | 0% | 6 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersKNSA · Kiniksa Pharmaceuticals International, plc
🔒 Subscribe to see trade entries
Pro members see exactly when Megna Michael R bought and sold KNSA.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Apr 9, 2026 | KNSA | Sell | 6,625 | $46.69 | $309K | −19.5% | CHIEF ACCOUNTING OFFICER | |
Oct 20, 2025 | KNSA | Sell | 37,255 | $38.72 | $1.4M | −48.0% | CHIEF ACCOUNTING OFFICER | |
Oct 20, 2025 | KNSA | Sell | 13,235 | $39.31 | $520K | −32.9% | CHIEF ACCOUNTING OFFICER | |
Sep 3, 2025 | KNSA | Sell | 11,000 | $34.84 | $383K | −22.4% | CHIEF ACCOUNTING OFFICER | |
Aug 4, 2025 | KNSA | Sell | 17,000 | $32.35 | $550K | −34.0% | CHIEF ACCOUNTING OFFICER | |
Jun 3, 2025 | KNSA | Sell | 15,211 | $28.75 | $437K | −31.9% | CHIEF ACCOUNTING OFFICER |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| KNSA | Kiniksa Pharmaceuticals International, plc | 6 | $3.6M |
Other insiders at Kiniksa Pharmaceuticals International, plc
7 other tracked filers at KNSA.